American Oncology Network, Inc. (AONC)
OTCMKTS
· Delayed Price · Currency is USD
4.815
+0.115 (2.45%)
Dec 26, 2024, 3:00 PM EST
American Oncology Network Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Operating Revenue | 1,579 | 1,266 | 1,138 | 938.24 | 714.68 | 318.69 |
| Other Revenue | 14.01 | 13.47 | 11.74 | 5.51 | 10.07 | 1.19 |
| Revenue | 1,593 | 1,279 | 1,150 | 943.75 | 724.74 | 319.89 |
| Revenue Growth (YoY) | 26.87% | 11.27% | 21.82% | 30.22% | 126.56% | - |
| Cost of Revenue | 1,501 | 1,189 | 1,052 | 863.47 | 651.79 | 294.25 |
| Gross Profit | 91.45 | 90.31 | 98.1 | 80.28 | 72.95 | 25.64 |
| Selling, General & Admin | 130.35 | 103.43 | 89.25 | 79.37 | 50.88 | 22.03 |
| Operating Expenses | 130.35 | 103.43 | 89.25 | 79.37 | 50.88 | 22.03 |
| Operating Income | -38.9 | -13.12 | 8.84 | 0.91 | 22.07 | 3.61 |
| Interest Expense | -7.39 | -6.42 | -3.42 | -1.42 | -1.12 | -1.29 |
| Interest & Investment Income | 3.28 | 1.33 | 0.15 | 0.13 | 0.03 | 0.14 |
| Earnings From Equity Investments | 0.15 | -0.26 | - | - | - | - |
| Other Non Operating Income (Expenses) | 0.1 | -8.26 | 0.29 | 0.74 | 0.18 | 0.07 |
| EBT Excluding Unusual Items | -42.76 | -26.73 | 5.87 | 0.36 | 21.17 | 2.53 |
| Merger & Restructuring Charges | -2.56 | -31.24 | -3.28 | - | - | - |
| Other Unusual Items | -3.76 | 22.28 | -2.59 | 0.11 | - | - |
| Pretax Income | -49.08 | -35.69 | - | 0.46 | 21.17 | 2.53 |
| Income Tax Expense | 2.64 | 0.38 | - | 0.46 | -0.78 | -0.25 |
| Earnings From Continuing Operations | -51.72 | -36.07 | - | - | 21.95 | 2.77 |
| Minority Interest in Earnings | 42.68 | 30.53 | - | - | - | - |
| Net Income | -9.04 | -5.54 | - | - | 21.95 | 2.77 |
| Preferred Dividends & Other Adjustments | 5.53 | 3.58 | - | - | 2.52 | 0.11 |
| Net Income to Common | -14.56 | -9.12 | - | - | 19.43 | 2.66 |
| Net Income Growth | - | - | - | - | 691.60% | - |
| Shares Outstanding (Basic) | 10 | 7 | - | - | - | - |
| Shares Outstanding (Diluted) | 10 | 7 | - | - | - | - |
| EPS (Basic) | -1.51 | -1.36 | - | - | - | - |
| EPS (Diluted) | -4.05 | -1.36 | - | - | - | - |
| Free Cash Flow | -46.21 | -30.4 | -13.98 | -34.66 | 25.02 | -29.91 |
| Free Cash Flow Per Share | -4.80 | -4.55 | - | - | - | - |
| Gross Margin | 5.74% | 7.06% | 8.53% | 8.51% | 10.07% | 8.01% |
| Operating Margin | -2.44% | -1.03% | 0.77% | 0.10% | 3.05% | 1.13% |
| Profit Margin | -0.91% | -0.71% | - | - | 2.68% | 0.83% |
| Free Cash Flow Margin | -2.90% | -2.38% | -1.22% | -3.67% | 3.45% | -9.35% |
| EBITDA | -29.36 | -4.67 | 15.56 | 6.99 | 25.73 | 4.62 |
| EBITDA Margin | -1.84% | -0.36% | 1.35% | 0.74% | 3.55% | 1.44% |
| D&A For EBITDA | 9.54 | 8.45 | 6.72 | 6.08 | 3.66 | 1.01 |
| EBIT | -38.9 | -13.12 | 8.84 | 0.91 | 22.07 | 3.61 |
| EBIT Margin | -2.44% | -1.03% | 0.77% | 0.10% | 3.05% | 1.13% |
| Effective Tax Rate | - | - | - | 100.00% | - | - |
| Revenue as Reported | 1,593 | 1,279 | 1,150 | 943.75 | 724.74 | 319.89 |
Source: S&P Capital IQ. Standard template. Financial Sources.